Few research categories are as loosely defined as the one labeled "cognitive" or "nootropic" peptides. The umbrella gets stretched over anxiolytic regulatory peptides, neurotrophic fragments, a sleep peptide, the pineal hormone, and a social-bonding nonapeptide—compounds that share almost nothing at the level of receptors or signaling. Grouping them by the outcome researchers happen to measure (attention, mood, sleep, stress reactivity) hides the fact that they reach those readouts by entirely separate routes.
This primer walks the cognitive-mood class as it appears in the Trulogic catalog and explains where the real mechanistic boundaries fall. The point is not to rank these compounds but to make the category legible: when several peptides are filed under one heading, the heading is usually describing a research question, not a shared biology.
What "Cognitive-Mood" Actually Bundles Together
The class as catalogued spans five distinct research stories:
- Selank — a synthetic heptapeptide derived from the endogenous immunomodulator tuftsin, studied as an anxiolytic and immunomodulatory agent.
- Semax — a synthetic fragment of adrenocorticotropic hormone (ACTH 4–10) with an added C-terminal extension, studied for neurotrophic and attention-related effects.
- DSIP (Delta Sleep-Inducing Peptide) — a nine-amino-acid peptide isolated from research on sleep regulation.
- Melatonin — not a peptide at all but an indoleamine hormone, included because circadian and sleep research overlaps with the mood literature.
- Oxytocin — a nine-amino-acid neurohypophyseal hormone studied in social cognition and affiliative-behavior models.
That list already tells you the label is a convenience. A tuftsin analog, an ACTH fragment, a sleep peptide, a tryptophan-derived hormone, and a posterior-pituitary nonapeptide do not belong to one pathway. They belong to one shelf.
The Russian Regulatory-Peptide Branch: Selank and Semax
Selank and Semax are frequently mentioned in the same breath because they share an origin story: both were developed at Russian research institutes as short, synthetically stabilized analogs of larger endogenous molecules, and both are the subject of a literature that is heavily concentrated in Russian-language journals.
Semax is built on the ACTH(4–10) sequence, a fragment of adrenocorticotropic hormone that, unlike the parent hormone, carries the behavioral and neurotrophic signal without the steroidogenic (corticosteroid-releasing) one. Research on Semax has focused on brain-derived neurotrophic factor (BDNF) expression and modulation of the dopaminergic and serotonergic systems in preclinical models. It has been investigated in models of ischemic injury and cognitive load.
Selank descends from tuftsin, an endogenous tetrapeptide with immunomodulatory activity. Its research framing is anxiolytic—studied for effects on anxiety-like behavior—with proposed mechanisms touching the GABAergic and monoaminergic systems and, reflecting its tuftsin lineage, on immune signaling and the expression of inflammatory mediators.
Both peptides are typically formulated for intranasal delivery in the research that exists, and both are short enough that mass-spec identity confirmation is straightforward. The key boundary: Semax leans neurotrophic/attentional, Selank leans anxiolytic/immunomodulatory. They are cousins by design philosophy, not by sequence or receptor.
The Sleep-and-Circadian Branch: DSIP and Melatonin
Here the category overlaps with sleep research, and the two members could not be more different in pedigree.
DSIP is a genuine peptide—the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu—first described decades ago in work on humorally transmitted sleep states. Despite its name, DSIP's relationship to actual sleep architecture remains one of the less-resolved questions in the literature. It has been studied as a neuromodulator with proposed roles in stress response, circadian regulation, and even chronic-pain models, but a clean, reproducible mechanism has never been pinned down. It is a useful case study in how a compound's name can outrun its evidence—a theme we covered in the peptide nomenclature primer.
Melatonin is the outlier that proves the category is about research questions, not chemistry. It is an indoleamine synthesized from serotonin, not a peptide, and its mechanism—MT1 and MT2 receptor agonism governing the circadian phase response—is among the best characterized of anything on this shelf. It sits in the cognitive-mood class only because sleep, circadian timing, and mood are studied as an interconnected system.
The boundary here is stark: melatonin has a defined receptor pharmacology and a large clinical literature; DSIP has a suggestive name and an unsettled mechanism. Filing them together is purely thematic.
The Neurohormone Branch: Oxytocin
Oxytocin is a nine-amino-acid peptide produced in the hypothalamus and released from the posterior pituitary. Classically a peripheral hormone of parturition and lactation, it earned its place in the cognitive-mood class through a large body of research on its central role—social recognition, pair bonding, trust, and modulation of amygdala reactivity in behavioral models.
Mechanistically, oxytocin acts on the oxytocin receptor (OXTR), a G-protein-coupled receptor, with cross-talk at vasopressin receptors owing to the close structural similarity between oxytocin and vasopressin (they differ by only two residues). Its inclusion here is the most defensible of the "mood" entries because the affiliative-behavior literature is substantial—though, as with the rest of the class, the research is about mechanism in models, not a directive to a reader.
Why the Boundaries Matter for Research Framing
Treating "cognitive peptides" as a monolith creates two recurring errors in how the literature gets summarized.
First, mechanism gets blurred. A claim that "peptides support cognition" collapses BDNF induction (Semax), GABAergic anxiolysis (Selank), circadian phase-shifting (melatonin), and OXTR-mediated social signaling (oxytocin) into one sentence. Those are four different experiments with four different readouts. A researcher comparing them needs to keep the pathways separate.
Second, evidence quality gets averaged. Melatonin and oxytocin sit on large, internationally replicated literatures. Selank and Semax rest on a research base concentrated in a narrower set of institutions and journals. DSIP's mechanism is frankly unresolved. Lumping them implies an even evidentiary footing that does not exist—exactly the kind of distinction our quality and methods coverage is built around.
The useful mental model is to read the category as a shelf of separate research programs that happen to report endpoints in the same broad domain. The shelf is real; the shared biology is mostly not.
FAQ
Is melatonin a peptide? No. It is an indoleamine hormone derived from serotonin. It appears in this class because sleep, circadian, and mood research overlap, not because of any structural kinship with the peptides here.
Why are Selank and Semax always discussed together? They share a development lineage—both are short, synthetically stabilized analogs of larger endogenous molecules (tuftsin and ACTH respectively) from the same research tradition. Their mechanisms differ: Semax is studied as neurotrophic/attentional, Selank as anxiolytic/immunomodulatory.
What makes DSIP different from the others? Its name promises a clear function—sleep induction—that the research has never cleanly confirmed. It remains a peptide with a suggestive label and an unsettled mechanism, useful as a reminder that names can outpace evidence.
Where can I read more about how these compounds are characterized? See the Trulogic library for compound-level pages and the quality section for how identity and purity are established.
This article is educational and for the laboratory research community. Trulogic Labs products are sold for laboratory and research use only and are not for human consumption.